Physical activity as a risk factor for prostate cancer diagnosis: A prospective biopsy cohort analysis

BJU International

Volumn 117, Issue 6, 2016, Pages E29-E35

  De Nunzio, Cosimo ^a,d   Presicce, Fabrizio ^a   Lombardo, Riccardo ^a   Cancrini, Fabiana ^a   Petta, Stefano ^a   Trucchi, Alberto ^a   Gacci, Mauro ^b   Cindolo, Luca ^c   Tubaro, Andrea ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Obstetric and Gynaecology Department   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

needle biopsy; physical activity; prostate; prostate cancer

Indexed keywords

ANTIBIOTIC AGENT; DUTASTERIDE; FINASTERIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROSTATE SPECIFIC ANTIGEN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PHYSICAL ACTIVITY; PHYSICAL ACTIVITY SCALE FOR THE ELDERLY QUESTIONNAIRE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; QUESTIONNAIRE; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; EXERCISE; IMAGE GUIDED BIOPSY; LARGE CORE NEEDLE BIOPSY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROSTATE; PROSTATIC NEOPLASMS;

AGED; BIOPSY, LARGE-CORE NEEDLE; EXERCISE; HUMANS; IMAGE-GUIDED BIOPSY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84966648782     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.13157     Document Type: Article

References (35)

1. Siegel RL, Miller KD, Jemal A,. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29
2. Wolf AM, Wender RC, Etzioni RB, et al. American Cancer Society Prostate Cancer Advisory Committee: American cancer society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010; 60: 70-98
3. Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM,. Physical activity and survival after prostate cancer diagnosis in the Health Professionals Follow-Up Study. J Clin Oncol 2011; 29: 726-32
4. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM,. Physical activity after diagnosis and risk of prostate cancer progression: data from the Cancer of the Prostate Strategic Urologic Research Endeavor. Cancer Res 2011; 71: 3889-95
5. Chan JM, Van Blarigan EL, Kenfield SA,. What should we tell prostate cancer patients about (secondary) prevention? Curr Opin Urol 2014; 24: 318-23
6. Allott EH, Masko EM, Freedland SJ,. Obesity and prostate cancer: weighing the evidence. Eur Urol 2013; 63: 800-9
7. Patel AV, Rodriguez C, Jacobs EJ, Solomon L, Thun MJ, Calle EE,. Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men. Cancer Epidemiol Biomarkers Prev 2005; 14: 275-9
8. Johnsen NF, Tjønneland A, Thomsen BL, et al. Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer 2009; 125: 902-8
9. Nilsen TI, Romundstad PR, Vatten LJ,. Recreational physical activity and risk of prostate cancer: a prospective population-based study in Norway (the HUNT study). Int J Cancer 2006; 119: 2943-7
10. Liu Y, Hu F, Li D, et al. Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis. Eur Urol 2011; 60: 1029-44
11. Norman A, Moradi T, Gridley G, et al. Occupational physical activity and risk for prostate cancer in a nationwide cohort study in Sweden. Br J Cancer 2002; 86: 70-5
12. Antonelli JA, Jones LW, Bañez LL, et al. Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy. J Urol 2009; 182: 2226-31
13. De Nunzio C, Trucchi A, Miano R, et al. The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy. J Urol 2009; 181: 1069-74
14. World Health Organization. Obesity and Overweight. Fact sheet no. 311, updated January 2015. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed May 2015
15. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421
16. Washburn RA, Smith KW, Jette AM, Janney CA,. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 1993; 46: 153-62
17. Parsons JK, Kashefi C,. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 2008; 53: 1228-35
18. Maserejian NN, Kupelian V, Miyasato G, McVary KT, McKinlay JB,. Are physical activity, smoking and alcohol consumption associated with lower urinary tract symptoms in men or women? Results from a population based observational study. J Urol 2012; 188: 490-5
19. Parsons JK, Messer K, White M, et al. Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol 2011; 60: 1173-80
20. Serfling R, Shulman M, Thompson GL, et al. Quantifying the impact of prostate volumes, number of biopsy cores and 5-alpha-reductase inhibitor therapy on the probability of prostate cancer detection using mathematical modelling. J Urol 2007; 177: 2352-6
21. Presti JC Jr, O'Dowd GJ, Miller MC, Mattu R, Veltri RW,. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 2003; 169: 125-9
22. De Nunzio C, Freedland SJ, Miano L, Finazzi Agrò E, Bañez L, Tubaro A,. The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis. Eur J Surg Oncol 2011; 37: 1025-9
23. De Nunzio C, Freedland SJ, Miano R, et al. Metabolic syndrome is associated with high grade gleason score when prostate cancer is diagnosed on biopsy. Prostate 2011; 71: 1492-8
24. Vidal AC, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL Jr, Freedland SJ,. Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study. Cancer Epidemiol Biomarkers Prev 2014; 23: 2936-42
25. Discacciati A, Orsini N, Wolk A,. Body mass index and incidence of localized and advanced prostate cancer -A dose-response meta-analysis of prospectivestudies. Ann Oncol 2012; 23: 1665-71
26. Ji LL, Gomez-Cabrera MC, Vina J,. Exercise and hormesis: activation of cellular antioxidant signalling pathway. Ann N Y Acad Sci 2006; 1067: 425-35
27. McTiernan A,. Mechanisms linking physical activity with cancer. Nat Rev Cancer 2008; 8: 205-11
28. Pierorazio PM, Ferrucci L, Kettermann A, Longo DL, Metter EJ, Carter HB,. Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging. BJU Int 2010; 105: 824-9
29. Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ,. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaPcells in vitro (United States). Cancer Causes Control 2002; 13: 929-35
30. Hellénius ML, Brismar KE, Berglund BH, de Faire UH,. Effects on glucose tolerance, insulin secretion, insulin-like growth factor1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men. J Intern Med 1995; 238: 121-30
31. Woodson K, Tangrea JA, Pollak M, et al. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men. Cancer Res 2003; 63: 3991-4
32. Hong J, Zhang G, Dong F, Rechler M,. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 2002; 277: 10489-97
33. De Nunzio C, Kramer G, Marberger M, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol 2011; 60: 106-17
34. Shephard RJ,. Limits to the measurement of habitual physical activity by questionnaires. Br J Sports Med 2003; 37: 197-206
35. De Nunzio C, Aronson W, Freedland SJ, Giovannucci A, Parsons JK,. The correlation between metabolic syndrome and prostatic diseases. Eur Urol 2012; 61: 560-70